<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
13.12.2011 13:15:00

STENTYS: Financial Events: Agenda 2012

Regulatory News:

STENTYS (Paris:STNT):

Event           Date * **
Q4 Full Year Sales 2011 25 January 2012
Annual Accounts 2011 7 March 2012
Q1 Sales 2012 2 May 2012
Q2 Sales 2012 25 July 2012
Half Year Results 2012 31 August 2012
Q3 Sales 2012 6 November 2012

Financial year ended 31 December

(Anzeige)Passende neue Barrier Reverse Convertibles

*Subject to modification
** Press releases are distributed after the financial markets closure

About STENTYS:
Based in Princeton, N.J., and Paris, STENTYS has developed a new generation of stents to treat acute myocardial infarction (AMI). Founded by Jacques Séguin, M.D., Ph.D., and Gonzague Issenmann, Stentys received the CE mark for its flagship products in 2010. Its self-apposing stents adapt to the anatomic changes of the arteries in the post-infarction phase and thus prevent the malapposition problems associated with conventional stents. Stentys has commenced its marketing activities in several European countries.
More information on www.stentys.com.

STENTYS is listed on NYSE Euronext Paris
ISIN : FR0010949404 – STNT

Analysen zu STENTYSmehr Analysen

Eintrag hinzufügen

Aktien Top Flop

Lonza Grp 538.40
2.12 %
CS Group 9.86
2.09 %
Swiss Re 74.48
1.97 %
Sika 190.60
1.87 %
Swiss Life Hldg 351.20
1.86 %
Geberit 484.30
0.39 %
Novartis 82.00
0.12 %
Adecco Group 44.51
0.07 %
Alcon 52.98
-0.04 %
Roche Hldg G 332.05
-0.27 %
Strukturierte Produkte: Beruhigen sich die Märkte? | BX Swiss TV

Aktien in diesem Artikel

STENTYS 0.41 0.00% STENTYS

Finanzen.net News

pagehit